|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Brief Genetics Report |
The Angiotensin-Converting Enzyme DD Genotype Is Associated With Glomerulopathy Lesions in Type 2 Diabetes
1 Department of Internal Medicine, University of Ferrara Medical School, Ferrara, Italy
2 Department of Medical and Surgical Sciences, University of Padova Medical School, Padova, Italy
3 Division of Endocrinology and Metabolic Diseases, University of Sassari Medical School, Sassari, Italy
Genetic factors are important in conferring diabetic nephropathy (DN) risk. The insertion/deletion (I/D) polymorphism of the ACE gene has been described to be associated with DN risk and progression. The renal lesions underlying DN in type 2 diabetes are heterogeneous; only a subset of patients, characterized by a faster decline of renal function, have diabetic glomerulopathy. This study explored the relations between diabetic glomerulopathy and the ACE genotype distribution in 77 type 2 diabetic patients with an albumin excretion rate 
20 µg/min. Using morphometric analysis of kidney biopsies, mesangial and mesangial matrix fractional volumes [Vv(mes/glom) and Vv(MM/glom)] and glomerular basement membrane (GBM) width were estimated. We found that 13 patients were II, 30 were ID, and 34 were DD. Clinical features and renal function were similar in the three groups; in contrast, the DD patients had the highest Vv(MM/glom) and GBM width. Subdividing patients in tertiles of GBM width and Vv(MM/glom), from the lowest (I) to the highest (III) values, the DD carriers had an odds ratio of 6.11 (95% CI 1.84–20.3) and 10.67 (2.51–45.36), respectively, for the likelihood of being in tertile III than I for GBM width and Vv(MM/glom). Multiple regression analysis revealed the I/D polymorphism as an independent determinant of GBM thickening in addition to diabetes duration and HbA1c. In conclusion, the ACE DD genotype is associated with diabetic glomerulopathy lesions, making the study of this polymorphism helpful in identifying those type 2 diabetic patients at higher risk of fast DN progression.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Wang, M. C.Y. Ng, W. Y. So, P. C.Y. Tong, R. C.W. Ma, C. C. Chow, C. S. Cockram, and J. C.N. Chan Prognostic Effect of Insertion/Deletion Polymorphism of the ACE Gene on Renal and Cardiovascular Clinical Outcomes in Chinese Patients With Type 2 Diabetes Diabetes Care, February 1, 2005; 28(2): 348 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jacobsen, L. Tarnow, B. Carstensen, P. Hovind, O. Poirier, and H.-H. Parving Genetic Variation in the Renin-Angiotensin System and Progression of Diabetic Nephropathy J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2843 - 2850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Andersen, L. Tarnow, F. Cambien, P. Rossing, T. R. Juhl, J. Deinum, and H.-H. Parving Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care, May 1, 2003; 26(5): 1501 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Mogensen Genetics and Diabetic Renal Disease: Still a big black hole Diabetes Care, May 1, 2003; 26(5): 1631 - 1632. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |